In a 72-year-old woman with a prior stent and right-leg atherosclerosis presenting with four days of groin-to-foot pain and right knee swelling, how should I evaluate and manage possible acute arterial occlusion versus deep-vein thrombosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Anticoagulation with Heparin and Urgent CTA to Differentiate Acute Arterial Occlusion from DVT

This patient requires immediate anticoagulation with heparin and urgent CT angiography (CTA) to determine whether she has acute arterial thrombosis/occlusion versus deep vein thrombosis—both are life- and limb-threatening emergencies in this clinical context.

Initial Assessment and Immediate Management

The combination of groin-to-foot pain over 4 days with knee swelling in a patient with known atherosclerosis and prior stent raises two critical diagnoses:

  1. Acute limb ischemia from stent thrombosis or progression of atherosclerotic disease
  2. Deep vein thrombosis with potential for pulmonary embolism

Critical Physical Examination Findings to Assess NOW

  • Pulse examination: Check femoral, popliteal, dorsalis pedis, and posterior tibial pulses bilaterally. Diminished or absent pulses suggest arterial occlusion 1
  • Neurological status: Test sensation and motor function—neurological deficits indicate advanced ischemia and poor prognosis 2
  • Skin assessment: Evaluate temperature, color, capillary refill, and any tissue compromise 3
  • Severity staging: Determine if limb is viable, threatened, or irreversibly ischemic

Immediate Anticoagulation

Start heparin immediately unless contraindications exist. Patients presenting with acute limb ischemia should receive anticoagulation therapy immediately, usually with heparin 1. This applies regardless of whether the diagnosis is arterial or venous thrombosis.

Diagnostic Imaging Algorithm

First-Line: CT Angiography (CTA)

CTA from pelvis with runoff is the diagnostic test of choice 1, 3. CTA provides:

  • Speed: Fast acquisition critical for acute presentations
  • Comprehensive visualization: Reveals exact nature and level of thrombosis, underlying atherosclerotic plaque, and stent patency
  • Treatment planning: Allows determination of appropriate endovascular versus surgical strategy

Alternative if CTA contraindicated (renal dysfunction, contrast allergy):

  • MR angiography (MRA) if time permits 1
  • Doppler ultrasound and ABI for patients unsuitable for CTA 1

Complementary Testing

  • Duplex ultrasound of lower extremity: Can evaluate for DVT simultaneously, particularly useful if knee swelling suggests venous pathology 4, 5
  • Hypercoagulability workup: Obtain PT, PTT, platelet count, and consider factor V Leiden, prothrombin C-20210a, protein C/S, antithrombin III—especially given atypical presentation with both arterial disease and swelling 1

Management Based on Diagnosis

If Acute Arterial Occlusion (Stent Thrombosis or Native Vessel)

For viable limbs with acute arterial thrombosis:

  • Continue therapeutic anticoagulation with heparin
  • Catheter-directed thrombolysis is the preferred initial approach for native vessel thrombosis when a guidewire can be passed 1
    • Agents: Alteplase, reteplase, or urokinase 1
    • Consider glycoprotein IIb/IIIa antagonist (abciximab) to reduce distal emboli 1
    • Mechanical thrombectomy options include suction embolectomy or rheolytic therapy 1

For immediately threatened limbs:

  • Surgical embolectomy or bypass if thrombolysis contraindicated or insufficient time 1
  • Endovascular techniques show similar 1-year limb salvage rates to surgery but with lower mortality 1

After acute treatment:

  • Address underlying lesion (stent restenosis, new atherosclerotic disease) with angioplasty/stenting or surgical bypass 1

If Deep Vein Thrombosis

For confirmed DVT:

  • Continue therapeutic anticoagulation (transition to LMWH, fondaparinux, or direct oral anticoagulant after initial heparin) 6, 7
  • Duration: Minimum 3-6 months for provoked DVT; consider extended therapy for unprovoked DVT 6, 7
  • Proximal DVT (above knee) requires full anticoagulation given high PE risk 4, 5
  • Distal DVT (calf only): Either anticoagulate or perform serial imaging at 1 week to exclude proximal extension 4

Common Pitfalls to Avoid

  1. Delaying anticoagulation: Start heparin immediately while awaiting imaging—do not wait for diagnostic confirmation 1
  2. Assuming single pathology: This patient could have both arterial and venous disease given her risk factors
  3. Inadequate imaging: Screening tests like plethysmography are insufficient for acute presentations 1
  4. Missing stent thrombosis: Prior stent placement increases risk of acute thrombotic occlusion, particularly if antiplatelet therapy was discontinued
  5. Underestimating urgency: Four days of symptoms with progression suggests evolving ischemia—limb viability window is closing

Risk Stratification for Outcomes

The presence of neurological deficits is an early poor prognostic sign for limb salvage 2. Immediate vascular surgery consultation is mandatory if:

  • Absent pulses with sensory/motor deficits
  • Skin changes suggesting advanced ischemia
  • CTA shows complete arterial occlusion without collaterals

This 72-year-old patient with known vascular disease requires urgent vascular surgery consultation, immediate heparin anticoagulation, and stat CTA to guide definitive limb-saving intervention within hours, not days.

Related Questions

What is the recommended thrombolytic treatment for deep vein thrombosis (DVT)?
A 66-year-old man with a recent deep‑vein thrombosis treated with oral anticoagulation now presents three weeks later with dyspnea, confusion and hyponatremia (serum sodium 127 mmol/L). What is the most likely cause of his symptoms?
What is the appropriate anticoagulation and overall management for an amputee patient with acute deep vein thrombosis and concurrent pneumonia?
What is the recommended treatment for acute deep vein thrombosis (DVT)?
Does a chronic deep vein thrombosis (DVT) require lifelong anticoagulation if the clot persists despite adherence to a direct oral anticoagulant (DOAC)?
For an elderly patient, how long should sucralfate (Carafate) be administered?
In a 59-year-old female with ulcerative colitis and hypothyroidism taking 137 µg levothyroxine (Synthroid), how should an elevated thyroid‑stimulating hormone with normal T3 and T4 be managed?
In a patient recently hospitalized for fluid overload and shortness of breath, with diagnoses of Bipolar II disorder, Generalized Anxiety Disorder, Psychophysiologic Insomnia, Cognitive Communication Deficit, Drug‑induced Subacute Dyskinesia, Morbid Obesity, and Moderate Recurrent Major Depressive Disorder, who is currently taking sertraline, loratadine, gabapentin, lisinopril, furosemide, topical nystatin‑triamcinolone and mupirocin, buspirone, aspirin, topiramate, albuterol, oxycodone‑acetaminophen, albuterol‑budesonide, and fluticasone propionate, would starting Austedo (lurasidone) be safe, and if so what initial dose should be used and what additional medications need to be started?
How should a rash on the knees and elbows in a patient taking fenofibrate be managed?
What infusion rate of a 1:10,000 epinephrine (adrenaline) solution should be used for anaphylactic shock without cardiac arrest?
What are the active ingredients in Breo Ellipta (fluticasone propionate/vilanterol) inhaler?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.